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In mammalian transcriptomes approximately 25% of 50 ends determined by Capped Analysis of Gene
Expression (CAGE) map to locations within spliced exons. The current study sought to determine if
the cytoplasmic capping complex participates in generating these downstream CAGE tags. 50-RACE
was used to amplify the uncapped ends of target transcripts that accumulate when cytoplasmic cap-
ping is blocked. Sequencing of these RACE products mapped the positions of uncapped ends either
exactly to or just downstream of archived CAGE tags. These ﬁndings support a role for cytoplasmic
capping in generating the downstream capped ends identiﬁed by CAGE.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The 50 ends of all mRNAs and lncRNAs have a methylguanosine
(m7G) ‘cap’ that is added co-transcriptionally as the ﬁrst step of
post-transcriptional processing. This served as the basis for devel-
opment of Capped Analysis of Gene Expression (CAGE) as a method
of identifying transcription start sites. However, in the ﬁrst broad
scale application of CAGE to mammalian transcriptomes a large
number of capped ends were identiﬁed that did not match to
known sites of transcription initiation [1]. At the time, we were
studying the decay of non-sense-containing b-globin mRNA in
erythroid cells [2]. In these cells, non-sense-containing human
b-globin mRNA is cleaved by SMG6 to generate metastable inter-
mediates [3] that were described as having a 50 cap [4]. The con-
cept of capped decay products raised several questions, including
whether these indeed had an m7G cap and how this might beadded when all of the proteins that catalyze capping were thought
to be present only in the nucleus. Further complicating matters
was the fact that capping enzyme transfers covalently-bound
GMP onto RNA with a 50-diphosphate end, and there was no known
mechanism for generating this substrate from 50-monophosphate
RNA. In pursuing this question we identiﬁed the cytoplasmic com-
plex that includes capping enzyme and a kinase that generates a
capping substrate from 50-monophosphate RNA [5]. We subse-
quently showed that the cytoplasmic capping complex assembles
on adapter protein Nck1, a protein with 3 SH3 domains and a sin-
gle SH2 domain that functions primarily in transducing receptor
tyrosine kinase signaling [6]. Importantly, Nck1 is only found in
the cytoplasm, and the binding of capping enzyme and the 50-
kinase to adjacent SH3 domains juxtaposes these two critical
enzymes in a manner that facilitates cytoplasmic capping.
In [7], cytoplasmic capping targets were identiﬁed by the sus-
ceptibility of uncapped 50 ends to in vitro degradation by Xrn1
when recovered from cells expressing a dominant negative form
of capping enzyme, termed K294A, that was modiﬁed to restrict
its distribution to the cytoplasm. Three classes of targets were
identiﬁed by position-dependent changes in probe intensity on
human exon arrays, two of which accumulate uncapped forms
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uncapped forms of these mRNAs was conﬁrmed by 4 independent
methods; increased susceptibility to in vitro degradation by Xrn1,
selective recovery of uncapped RNAs following ligation of an RNA
adapter and hybridization to a biotin-tagged antisense DNA, selec-
tive exclusion from a cap afﬁnity column containing a heterodimer
of eIF4E bound to eIF4G, and the appearance of products by 50-
RACE only when cytoplasmic capping is blocked. The latter proved
to be particularly important in that it identiﬁed full-length tran-
scripts and 50-truncated forms of the same RNAs.
We wondered if the uncapped ends of shorter transcripts that
appeared by 50-RACE of RNA from capping inhibited cells might
correspond to downstream capping sites identiﬁed by CAGE. Using
positional data of CAGE tags from ENCODE [8] we designed primers
to several of the transcripts for which shortened forms appeared by
50-RACE [7]. We show that uncapped ends that accumulate when
cytoplasmic capping is blocked map either at or near CAGE tags,
thus providing the ﬁrst direct evidence of a functional role for cyto-
plasmic capping in generating this form of transcriptome diversity.
2. Materials and methods
2.1. Downstream CAGE tag correlations
Poly-A +/, hg19-aligned cytoplasmic CAGE tags were down-
loaded from the UCSC FTP data server [9] for the K562 cell line
(Table 1). Reads were combined across the 4 samples (oneTable 1
CAGE libraries used.
wgEncodeRikenCageK562CytosolPapAln.bam
wgEncodeRikenCageK562CytosolPapAlnRep1.b
wgEncodeRikenCageK562CytosolPapAlnRep2.b
wgEncodeRikenCageK562CytosolPamAln.bam
wgEncodeRikenCageAlignmentsGm12878Cyto
wgEncodeRikenCageAlignmentsGm12878Nucl
wgEncodeRikenCageAlignmentsGm12878Nucl
wgEncodeRikenCageAlignmentsH1hescCellLon
wgEncodeRikenCageAlignmentsHepg2CytosolL
wgEncodeRikenCageAlignmentsHepg2Nucleolu
wgEncodeRikenCageAlignmentsHepg2Nucleus
wgEncodeRikenCageAlignmentsHuvecCytosolL
wgEncodeRikenCageAlignmentsK562Chromati
wgEncodeRikenCageAlignmentsK562CytosolLo
wgEncodeRikenCageAlignmentsK562CytosolLo
wgEncodeRikenCageAlignmentsK562Nucleolu
wgEncodeRikenCageAlignmentsK562Nucleopla
wgEncodeRikenCageAlignmentsK562NucleusL
wgEncodeRikenCageAlignmentsK562NucleusL
wgEncodeRikenCageAlignmentsK562Polysome
wgEncodeRikenCageAlignmentsNhekCytosolLo
wgEncodeRikenCageAlignmentsNhekNucleusL
wgEncodeRikenCageAlignmentsProstateCellLo
Table 2
Oligonucleotides used.
Oligonucleotide name Sequence
RNA_RACE_Adaptor GUUCAGAGUUCUACAG
RACE_Forward GTTCAGAGTTCTACAGT
ZNF207_nTail (1725-1699)Rev GTCCAATAGTTCCTGGTA
SARS_30 (1838-1815)Rev ATCAATGATGGGTCCCT
ITGB1_sTail (3678-3653)Rev GGGCAACTCAAATGGTG
ZNF207-A (326-301)Rev ACCTGCATGCAATGAAT
ZNF207-B (649-627)Rev TGGCATTAATGGAGGTA
ZNF207-C (1192-1169)Rev GTACTATTTAAGGGTTTG
SARS (160-134)Rev CTTGAAGCGCTTCTCCTG
ITGB1-A (469-446)Rev AATTTTAATGTAAATGTC
ITGB1-B (1705-1681)Rev TTTCATTTGTATTATCCC
ITGB1-C (2296-2273)Rev CCAATAAGAACAATTCCpoly-A, three poly-A+ samples), and genomic coordinates for 50-
ends of reads were mapped to transcript coordinates for Gencode
v19 transcripts [10], downloaded from the UCSC Table Browser
[11]. Transcripts in the top quartile of total CAGE expression
(which had no signiﬁcant difference in total CAGE tags across cat-
egories, compared using Student’s t-test) were classiﬁed as recap-
ping targets or controls based on [7], and as containing a
downstream CAGE tag when at least one location downstream of
the annotated translation start site had a minimum CAGE coverage
of 10 reads. Fisher’s exact test was performed on the distribution of
the number of transcripts across these categories using the R
Statistical Computing Package, version 3.1.1 [12].
2.2. Cell culture and preparation of cytoplasmic RNA
Tetracycline-inducible U2OS cells stably transfected with
pcDNA4/TO/myc-K294-DNLS+NES-Flag (K294A) were cultured in
McCoy’s medium (Gibco) supplemented with 10% fetal bovine
serum [5,7]. 3  106 log-phase cells were split into 150 mm tissue
culture dishes followed 24 h later by addition of 1 lg/ml doxycy-
cline to induce K294A. The medium was removed 24 h later, the
cells were rinsed twice with ice-cold phosphate buffered saline
and suspended with a cell scraper. These were recovered by centri-
fugation for 5 min at 1000g, the pellet was suspended in 5 vol-
umes of lysis buffer (20 mM Tris–HCl, pH 7.5, 150 mM NaCl,
5 mM MgCl2, 1 mM DTT, 0.2% NP-40, 80 U/ml RNaseOUT (Invitro-
gen)) and incubated on ice for 10 min with gentle agitation. NucleiFig. 1A
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Use(s)
UCCGACGAUC Ligation reaction
CCGACGATC 1 and 2 nested PCR
TGTGGGAAG cDNA synthesis and 1 nested PCR
ATGCCCA cDNA synthesis and 1 nested PCR
AGAAGTAAA cDNA synthesis and 1 nested PCR
AGCTAAGC 2 nested PCR
TGCCT 2 nested PCR
AAATC 2 nested PCR
CGTCTCTC 2 nested PCR
TGTGG 2 nested PCR
TCTTCC 2 nested PCR
AGCAAC 2 nested PCR
Fig. 1. mRNA targets of cytoplasmic capping have a greater representation of
downstream CAGE tags than non-target mRNAs. (A) The datasets of cytoplasmic
capping targets and control transcripts from [7] and from the databases of K562
cells in Table 1 were compared using Fisher’s Exact Test to determine the
correlation between cytoplasmic capping targets and the presence of downstream
CAGE tags within spliced exons. (B–D) The positions and number of CAGE tags are
shown across the length of the predominant isoforms of SARS (B), ZNF207 (C) and
ITGB1 mRNA (D). The location of primers used for 50-RACE are identiﬁed by arrows
above the plots for each transcript.
Fig. 2. Appearance of uncapped 50-ends as a consequence of inhibiting cytoplasmic
capping. (A) Cytoplasmic and nuclear extracts were prepared from uninduced and
doxycycline-treated U2OS cells stably transfected with a tetracycline-inducible
K294A transgene [5]. Restricted expression of K294A to doxycycline-treated cells
was demonstrated by Western blotting with antibody to the N-terminal Myc tag on
the protein, and Western blotting was performed with antibodies to a-tubulin and
histone H3 to demonstrate that cytoplasmic extract was free of nuclear contam-
ination. (B) RNA recovered from cytoplasmic extracts of control and doxycycline-
treated cells was depleted of ribosomal RNA, followed by primer ligation onto
uncapped 50-ends. 50-RACE was performed for ZNF207 mRNA using primers A and B
in Fig. 1C, followed by electrophoresis on a 2% agarose gel. Lane 3 contains a 100 bp
ladder (M).
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cytoplasmic RNA was recovered from the supernatant fraction
with Trizol (Life Technologies) according to the manufacturer’sinstructions. The recovered RNA was resuspended in water and
treated with DNase I (5 U/50 ll) (Life Technologies) according to
the manufacturer’s instructions, and the reaction was stopped by
the addition of EDTA and denaturation at 65 C for 10 min.
2.3. Nuclear extracts and Western blotting
The nuclear extract was made by resuspending the pelleted
nuclei from above in the same lysis buffer and sonicating four
times using a micro tip at 40% amplitude on continuous setting
for 4 s. Each sample was incubated on ice for 1 min between soni-
cations. Samples were then centrifuged at 16000g for 10 min at
4 C and the supernatant was used for further analysis. Protein lev-
els of nuclear and reserved cytoplasmic extracts were determined
by Bradford assay (Biorad). Western blotting was performed by
loading either 10 or 20 lg of protein into precast 4–15% gradient
or 10% Mini-PROTEAN TGX gels (Biorad) and transferring to nitro-
cellulose (Amersham) or Immobilon-FL PVDF (EMD Millipore)
membranes. The resulting membranes were blocked in 5% non-
fat milk in Tris-buffered saline (TBS). Blots were probed (overnight
at 4 C) with primary antibodies targeting Histone H3 (rabbit, Cell
Signalling), a-tubulin (mouse, Sigma), or c-Myc (mouse, Santa
Cruz), that were diluted 1:1000, 1:15000, 1:1000 respectively with
1%milk in TBS +0.05% Tween-20 (TBST). Secondary antibodies, goat
anti-Mouse IRDye 800CW (Rockland) or goat anti-Rabbit Alexa-
ﬂour 680 (Invitrogen), were used at 1:10000 dilutions in 1% milk
in TBST and visualized with a Licor Odyssey imager.
2.4. Identiﬁcation of CAGE tags for analysis
Sequences of the most common isoforms of ITGB1, SARS, and
ZNF207 from [7] were aligned against human genome hg18 using
BLAT [13] and the result was parsed for the genomic locations of all
exons of the transcripts. Raw sequence data ﬁles from 18 ENCODE
CAGE libraries (aligned to hg18) [8] that were available at the time
were obtained from the UCSC Genome Browser in tag-aligned for-
mat (Table 1). A custom script was used to extract all tags within
100 nucleotides of the target transcripts, associate the position of
each CAGE tag with the 50 end and 30 end of the read for genes in
the forward and reverse strand, respectively, using the exon
Fig. 3. Map of 50 RACE products of SARS and ZNF207 mRNA. The sequences upstream of primers used for 50-RACE of SARS (A) and ZNF207 (B–D) are shown on the horizontal
axes with the positions of CAGE tags compiled from the data sets in Table 1 identiﬁed with vertical lines. The vertical axis represents the number of CAGE tags for any given
location. Arrows under each sequence denote the locations of uncapped ends as determined by the junction between the ligated adapter and the target mRNA. Asterisks
denote RACE products that exactly match CAGE tags.
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dinates, remove tags from transcript positions with encoded GGs
as well as tags supported by fewer than 10 reads, and ﬁnally tally
the tag counts across all experimental conditions. Primers selected
for use in 50 RACE were located 150 bases 30 to sizeable peaks or
clusters of CAGE tags.
2.5. 50RACE and PCR
Cytoplasmic RNA (5 lg) was depleted of ribosomal RNA using a
RiboZero kit as directed by the manufacturer (Epicentre). One ﬁfth
of the resulting RNA (5 ll) was mixed with 1.5 ll of 100 lM RNA
RACE Adaptor oligonucleotide (Table 2), 3.5 ll DMSO, and 15 ll
of water. Reactions were incubated at 65 C for 5 min followed
by rapid chilling on ice. 10 ll of ligation mix two (3.5 ll 10
RNA Ligase 1 buffer, 3.5 ll of 10 mM ATP, and 3 ll of RNA Ligase
1) was added to each sample, followed by gentle mixing and incu-
bation for 16 h at 16 C. Reactions were stopped with the addition
of 5 ll of 25 mM EDTA and inactivated by incubation at 65 C for
15 min. One fourth of the ligation reaction was used for reverse
transcription with Superscript III (Life Technologies) according to
the manufacturer’s instructions. cDNA synthesis was primed using
gene-speciﬁc primers listed in Table 2, followed by nested PCRperformed using 5% of the cDNA, the adapter-speciﬁc RACE primer
and the indicated transcript-speciﬁc primers. Primary nested PCR
products were puriﬁed using DNA Clean and Concentrator-5 col-
umns (Zymo) and secondary PCRs were performed using CAGE-
directed primers (Table 2). The reactions were separated on 2%
agarose gels and each of the ampliﬁed products was recovered
using a gel extraction kit (Syd Labs). Puriﬁed DNA was sequenced
at the Plant–Microbe Genomics Facility at The Ohio State Univer-
sity. The resulting sequences were mapped to their respective
genes using BLAST [14] from NCBI.
3. Results and discussion
3.1. Target selection for 50-RACE
In [7], cytoplasmic capping targets were identiﬁed by the sus-
ceptibility of uncapped ends to in vitro degradation by Xrn1, par-
ticularly when cap homeostasis was disrupted by expression of
an inactive form of cytoplasmic capping enzyme (K294A). For the
most part, 50-RACE products were only observed with RNA that
was recovered from K294A-expressing cells, and some were miss-
ing portions from their 50 ends. While it was conceivable that the
50-truncated transcripts were degradation products, the fact that
Fig. 4. Map of 50 RACE products of ITGB1 mRNA. The locations of CAGE tags and ligated 50 ends of ITGB1 mRNA are shown as described in the legend to Fig. 3.
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cytoplasmic capping suggested they might instead correspond to
downstream capped ends identiﬁed by CAGE [1,8].
We ﬁrst determined if there was any difference in downstream
CAGE tags in recapping targets versus control transcripts identiﬁed
in [7]. In Fig. 1A the datasets of cytoplasmic capping targets and
control transcripts were compared with the CAGE databases indi-
cated in Table 1 using Fisher’s Exact Test. The results showed there
is a signiﬁcantly greater representation of downstream CAGE tags
in cytoplasmic capping targets (87%) than control transcripts
(75%, P = 7.3  1040).
3.2. Relationship of CAGE tags to recapping sites
Three transcripts (SARS, ZNF207 and ITGB1) were selected for
further analysis. Each of these was shown previously by 50-RACE
to accumulate shortened, uncapped forms when cytoplasmic cap-
ping is blocked [7]. The locations of downstream CAGE tags relative
to mRNA 50 ends of these mRNAs are shown in Fig. 1B–D. Each has
a cluster of CAGE tags toward the 50-end, and ZNF207 and ITGB1
have clusters of CAGE tags further downstream (Fig. 1B–D). The
arrows in each of these ﬁgures identify the locations of primers
that were used for PCR ampliﬁcation of 50-RACE products for each
of these clusters.
Prior to mapping uncapped ends we conﬁrmed that uncapped
forms appear as a result of inhibiting cytoplasmic capping. We pre-
viously described the development and application of a line of
U2OS cells that expresses the inhibitory K294A form of cytoplas-
mic capping enzyme under a tetracycline-inducible promoter[5,7]. The Western blots in Fig. 2A show K294A is only expressed
in doxycycline-treated cells, that its distribution is restricted to
the cytoplasm, and that the cytoplasmic extract used to recover
RNA for 50-RACE was free of nuclear contamination. To conﬁrm
that uncapped transcripts appear when cytoplasmic capping is
blocked, cytoplasmic RNA recovered from extracts of uninduced
and K294A-expressing cells was depleted of ribosomal RNA and
ligated to an RNA adapter. 50-RACE was then performed using
two of the primers for ZNF207 mRNA shown in Fig. 1C. The selec-
tive appearance of products from K294A-expressing cells (Fig. 2B)
conﬁrmed that uncapped 50 ends appear within the body of
ZNF207 mRNA as a consequence of inhibiting cytoplasmic capping.
Next, each of the 3 mRNAs in Fig. 1B–D were ampliﬁed by 50-
RACE using the primers indicated on that ﬁgure, the products were
gel puriﬁed, sequenced, and the positioning of the ligated primer
was used to identify the location of uncapped ends. SARS was
the ﬁrst mRNA to be examined because it has a limited number
of CAGE tags that cluster toward the 50 end. The black bars in
Fig. 3A show the locations of the CAGE tags assembled from the
ENCODE data listed in Table 1, and the arrows indicate the loca-
tions of uncapped 50 ends as determined by the junction between
the ligated primer and the mRNA. In agreement with the 50-RACE
data in [7] this captured the uncapped 50 end as well as an
uncapped end located in the ﬁrst major cluster of CAGE tags
(arrows). This analysis was then extended to ZNF207 (Fig. 3B–D)
and ITGB1 (Fig. 4). Because each of these mRNAs have 3 major clus-
ters of downstream CAGE tags 50-RACE was performed with 3 dif-
ferent downstream primers (Fig. 1C and D). Here the results were
more variable. For both ZNF207 and ITGB1 50-RACE identiﬁed
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U2OS cells have less Xrn1 than most commonly used cell lines,
and to be consistent with our previous work [7] no steps were
taken to inactivate Xrn1. Because of this, some of the ends identi-
ﬁed here may not match precisely to CAGE tag locations due to
in vivo 50 end trimming.
Finally, there were a number of instances where downstream
CAGE tags did not have matching 50-RACE products. This was to
be expected, ﬁrst because the CAGE tag positions were a summa-
tion of data generated using total, cytoplasmic and nuclear RNA,
whereas only cytoplasmic RNA was used here for 50-RACE. By def-
inition this will remove from our analysis transcripts that never
make it out of the nucleus, such as those with improperly methyl-
ated caps. Second, CAGE data were generated from 7 different cell
and tissue types, and the number and locations of CAGE tags varied
between these. Thus, cell type differences contribute to the
observed differences between CAGE tags and uncapped ends
detected by 50-RACE.
In contrast to mammals, downstream CAGE tags are absent
from the Drosophila transcriptome [15]. This raised the possibility
that Drosophila lacks one or more of the biochemical mechanisms
needed for downstream capping, and it was this idea that led us
to perform the phylogenetic analysis in [6] that identiﬁed the basis
for this. That analysis identiﬁed a proline rich sequence at the
C-terminus of mammalian capping enzyme whose absence from
Drosophila capping enzyme precludes it is binding to Nck1, and
therefore, its ability to participate in cytoplasmic capping. These
ﬁndings, together with results in the current study, point to cyto-
plasmic capping being responsible for at least a portion of the
capped ends that constitute the downstream CAGE tags of verte-
brate transcriptomes.
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